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The catechol-O-methyltransferase (COMT) Val158Met polymorphism impacts cortical
dopamine (DA) levels and may influence cortical electrical activity in the human
brain. This study investigated whether COMT genotype influences resting-state
electroencephalogram (EEG) power in the frontal, parietal and midline regions in healthy
volunteers. EEG recordings were conducted in the resting-state in 13 postmenopausal
healthy woman carriers of the Val/Val genotype and 11 with the Met/Met genotype. The
resting EEG spectral absolute power in the frontal (F3, F4, F7, F8, FC3 and FC4), parietal
(CP3, CP4, P3 and P4) and midline (Fz, FCz, Cz, CPz, Pz and Oz) was analyzed during
the eyes-open and eyes-closed conditions. The frequency bands considered were the
delta, theta, alpha1, alpha2, beta1 and beta2. EEG data of the Val/Val and Met/Met
genotypes, brain regions and conditions were analyzed using a general linear model
analysis. In the individuals with the Met/Met genotype, delta activity was increased in the
eyes-closed condition, theta activity was increased in the eyes-closed and in the eyes-
open conditions, and alpha1 band, alpha2 band and beta1band activity was increased
in the eyes-closed condition. A significant interaction between COMT genotypes and
spectral bands was observed. Met homozygote individuals exhibited more delta, theta
and beta1 activity than individuals with the Val/Val genotype. No significant interaction
between COMT genotypes and the resting-state EEG regional power and conditions
were observed for the three brain regions studied. Our findings indicate that the COMT
Val158Met polymorphism does not directly impact resting-state EEG regional power, but
instead suggest that COMT genotype can modulate resting-state EEG spectral power in
postmenopausal healthy women.
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Introduction
Catechol-O-methyl transferase (COMT) is the major mammalian enzyme involved in the
metabolic degradation of released dopamine (DA) and accounts for more than 60% of
DA degradation in the frontal cortex (Bertocci et al., 1991). The gene that encodes the
COMT enzyme may influence cognition (Barnett et al., 2008; Solís-Ortiz et al., 2010) and
brain function (Heinz and Smolka, 2006) through its effects on dopaminergic function.
The human COMT gene contains a functional polymorphism in the coding sequence
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(a G to A substitution), resulting in a valine (Val) to methionine
(Met) substitution at codon 158 (Val158Met), which affects
the thermostability of the enzyme (Lachman et al., 1996).
As a result of the allelic differences in enzymatic activity,
Val carriers have less DA activity in the prefrontal cortex.
The Met/Met polymorphism produces a less active enzyme,
resulting in higher DA levels than in individuals with the
Val/Val or the Val/Met polymorphism (Egan et al., 2001;
Chen et al., 2004). The enzyme containing Met is unstable
at 37◦C and has one-third to one-fourth of the activity of
the Val enzyme (Spielman and Weinshilboum, 1981; Lotta
et al., 1995). The alleles are codominant, because heterozygous
individuals have enzyme activity that is midway between
homozygous individuals (Weinshilboum et al., 1999). Therefore,
heterozygous phenotypes were not included in this study. The
more robust statistical differences in COMT have been observed
in heterozygous individuals with the Val/Val or Met/Met
genotypes. Several experimental animal and human studies
implicate COMT allelic variations in tuning cortical DA levels
and consequent function (Diamond, 2007; Witte and Flöel,
2012). These studies indicate that this functional polymorphism
accounts for most of the human variation in peripheral
COMT activity. Therefore, an individual’s COMT genotype
might also contribute to differences in prefrontal function
(Akil et al., 2003).
In humans, COMT has gathered increasing interest in
recent years with respect to the genetic disposition towards
schizophrenia (Ehlis et al., 2007), anxiety traits (Lee and Prescott,
2014), depression (Shen et al., 2014), emotional disorders
(Gohier et al., 2014) and deficits in cognitive prefrontal functions
(Solís-Ortiz et al., 2010). Several studies have also focused on
COMT because it is highly expressed throughout both the
prefrontal cortex and the limbic system (Hong et al., 1998;
Matsumoto et al., 2003), brain areas involved in cognition and
emotion.
In humans, a number of studies have examined the influence
of COMT on the electroencephalogram (EEG), a measure
of brain function, because the dopaminergic system impacts
cortical activity and reflects basicmechanisms of brain activation.
The EEG is a recording of the rhythmical electrical activity
of the brain that is thought to derive from extracellular
current flow associated with summated postsynaptic potentials in
synchronously activated, pyramidal cells that are perpendicular
to the cortical surface (Mado and Zani, 2003; Miller, 2007). EEG
measures the electrical cortical activity in the brain, with high
temporal resolution, provides a direct measure of the present
functional state of the brain and of its different levels of arousal
(Niedermeyer, 1993a; Buzsáki, 2006). Resting EEG contains
abundant information predictive of performance on several
cognitive tasks (Basar and Güntekin, 2008; Solís-Ortiz et al.,
2012) and has been useful for the diagnosis of neurodegenerative
diseases (Fonseca et al., 2011). Moreover, the EEG technique
enables the analysis of the effects of genetic polymorphisms on
human brain function (Hodgkinson et al., 2010).
Human studies using EEG markers have demonstrated that
COMT polymorphisms can affect the resting-state EEG global
power, even though there are only a few studies reporting this in
the literature. In young healthy men, Val allele carriers showed
lower power than Met allele carriers within the upper α range,
which was associated with executive performance in wakefulness
(Bodenmann et al., 2009). In healthy subjects of both genders,
the Val allele was associated with increased EEG delta/theta
activity at Pz-Fz and increased extraversion scores (Wacker and
Gatt, 2010). In women, the Met/Met genotype was associated
with higher anxiety scores and low-voltage alpha resting EEG
(Enoch et al., 2003). Other studies have found enhanced error
positivity in individuals with the Met/Met genotype compared
with Val carriers (Frank et al., 2007), low functional connectivity
in healthy young women with the Met/Met genotype (Lee et al.,
2011) and lower baseline prefrontal activation in individuals with
the Val/Val genotype (Gianotti et al., 2012).
The effect of the COMT genotype on EEG activity in
postmenopausal healthy women is not well known. One
feature of women over 50 years is a decrease in serum levels
of estrogens that produces significant physiological effects
(Santoro and Tortoriello, 1999). There is an influence on
dopaminergic function in striatum (Becker, 2000). Estrogen
functions as a multipurpose brain messenger that can interact
with neurotransmitter systems at critical brain nuclei and
facilitate neuronal function via gene expression and transmitter-
gated ion channels (Ostlund et al., 2003). It has been reported
that estrogen is a regulator of COMT promoter activity. There
are two estrogen response elements in the COMT promoter
and that estrogen at physiological concentrations inhibits COMT
mRNA expression in cells expressing estrogen receptors (Xie
et al., 1999). The estrogen-mediated decrease in COMT mRNA
is accompanied by a decrease in COMT activity (Jiang et al.,
2003). This inhibitory regulation by estrogens is consistent with
evidence that women with high estrogen states have higher
COMT activity than other women with low levels of estrogens
(Briggs and Briggs, 1973). Compared with men, women have
higher striatal [18F] fluorodopa uptake, suggestive of greater
presynaptic DA synthesis (Laakso et al., 2002), a lower D2
receptor affinity that reflects higher DA levels (Pohjalainen et al.,
1998) and greater DA transporter uptake (Mozley et al., 2001).
However, estrogenic state (menopausal or menstrual cycle) has
not been fully taken into account in EEG studies of COMT
activity and may be a significant confounder (Harrison and
Tunbridge, 2008). DA mechanisms may be particularly relevant
in prefrontal functions in women with low levels of estrogen in
the middle age (Solís-Ortiz et al., 2010).
Because of the different regional expression patterns
of COMT in postmortem human brains, the Val158Met
polymorphism is thought to modulate dopaminergic
neurotransmission most prominently in the prefrontal cortex,
(Akil et al., 2003; Chen et al., 2004). Whether the differential
expression of COMT modulates resting-state EEG regional
power in postmenopausal healthy women remains unexplored.
The aim of the current study was to examine the effects of the
COMTVal158Met genotype on EEG activity in the frontal region,
which is associated with executive functions such as self-control,
planning, reasoning, abstract thinking and working memory
(Baddeley and Logie, 1999). This study also seeks to determine
whether COMT genotype also impacts EEG activity in the
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parietal region, an area associated with attention, sensory, verbal
and visuospatial processes, and in the midline region, which
is involved in attention, cognitive and emotional processing
(Pizzagalli et al., 2006). This study hypothesized that the resting-
state EEG power spectra in the frontal, parietal and midline
regions during the eyes-closed and eyes-open states would be
different depending on the COMT genotype in postmenopausal
healthy women.
Materials and Methods
Participants
A total of 74 womens responded to recruitment advertisements.
All respondents were genotyped for the Val158Met single
COMT polymorphism. Of the 74 respondents, 24 healthy
postmenopausal female volunteers between 48 and 65 years old
with intact uteruses were selected based on their genotypes,
13 homozygous Val/Val allele carriers and 11 homozygous
Met/Met allele carriers. The sample size of 24 womens with the
Val158Met polymorphism was calculated to yield an expected
power of 0.91 to detect a difference of 10% on EEG spectral
bands with a two-sided significance level of α = 0.05. Since
COMT enzyme activity is downregulated by estrogen (Jiang et al.,
2003) and seems to affect the prefrontal cortex (Schendzielorz
et al., 2011), only postmenopausal women were selected for
this study. All women were given a medical history interview
to assess their health status. To participate in the study,
women must have been amenorrheic for at least 12 months
and have no history of cardiovascular, metabolic, endocrine
or malignant diseases. None of the participants were taking
any type of medication at the time of the study and none
had ever received hormonal treatment. The participants did
not report a history of severe sleep disturbances. Participants
were tested in a single session (between 09:00 h and 10:00 h)
by one trained female. Participants were instructed to abstain
from caffeine, alcohol and smoking and to sleep for 8 h on
the day prior to testing. This study was approved by the
Ethics Committee of the Department of Medical Sciences at the
University of Guanajuato for Research on Human Subjects and
is in accordance with the Declaration of Helsinki. All subjects
provided written informed consent prior to participating in
the study.
Genotyping
Genomic DNA was extracted from peripheral blood leukocytes
using standard methods. The portion of exon 4 that contains
the polymorphic site was amplified by PCR. The total
reaction volume was 27 µl and contained 25 pmol of
forward (5′-TACTGTGGCTACTCAGCTGTGC-3′) and reverse
(5′-GTGAACGTGGTGTGAACACC -3′) primers, 100 ng of
genomic DNA, 2 mM MgCl2, and 250 µM dNTPs. The PCR
conditions were as follows: denaturation at 94◦C for 1 min,
followed by 30 cycles of denaturation (94◦C, 30 s), annealing
(56◦C, 30 s), and extension (72◦C, 30 s), and a final extension
cycle at 72◦C for 10 min. The PCR products were digested
at 37◦C overnight with Hsp92ll (Promega), electrophoresed in
a 4% agarose gel, and stained with ethidium bromide. There
were two expected digestion products: Val/Val homozygote
(114 bp), and Met/Met homozygote (96 bp) (Worda et al.,
2003).
EEG Recordings
All EEG records began at 09:00 h and finished at 10:00 h
during rest, with the subjects’ eyes open and closed. During the
recordings, participants were instructed to relax comfortably in
a chair and place their chin on an individually adjusted head-
rest. The recording session consisted of a 3 min period with
eyes closed and a 3 min period with eyes open. EEG responses
were recorded with 32 tin electrodes using an electrode cap
(Compumedics Neuroscan Quick-Cap™, Charlote, NC, USA).
The electrodes were positioned according to the International
10--20 system. Eye movements were recorded by an electrode
1 cm lateral to the left eye. Electrode impedance was less than
10 kΩ. EEGs were recorded on a 40 channel Scan model digital
amplifier (NuAmps, Neuroscan, Charlote, NC, USA), set to
pass frequencies from 0.5 to 35 Hz and gain 19. EEG activity
was recorded on a personal computer at a sampling rate of
512 Hz and was analyzed off-line with SCAN 4.3 data analysis
software (Compumedics Neuroscan, Charlote, NC, USA). EEG
activity was carefully inspected for eye movement artifacts
using the Artifact Rejection command integrated into the Edit
Module, with appropriate parameters. Artifact rejection (eye
movements, blinks, muscular activation, or movements artifacts)
was performed on the raw EEG trace by posing a market
at the onset of the artifact signal and a further market at
the end of the artifact. The artifact segments (the EEG signal
between the two markers) were excluded from the analysis.
The free-epochs average of each subject from the resting-state
EEG (Möcks and Gasser, 1984) was Fast Fourier transformed
(FFT). Using traditional definitions of bands for characterizing
EEG frequency spectra of normal EEG of the waking adult
(Niedermeyer, 1993b; Davidson et al., 2000), the absolute power
(Hz) was obtained for the following bands: delta, 0.5--4.0 Hz;
theta, 4.0--8.0 Hz; alpha1, 8.0--11.0 Hz; alpha2, 11.0--14.0 Hz;
beta1, 14.0--25.0 Hz; and beta2, 25.0--35.0 Hz. All bands of resting
EEG power in the frontal (F3, F4, F7, F8, FC3, FC4), parietal
(CP3, CP4, P3, P4) and midline (Fz, FCz, Cz, CPz, Pz and Oz)
cortical regions, were analyzed to determine whether genotype-
dependent differences between Val/Val and Met/Met carriers
with eyes open and closed vary with scalp location. At least 100 s
of EEG recording were analyzed for each condition (eyes open
and eyes closed) in the all participants. The average time analyzed
was 124± 30 s.
Statistical Analysis
Statistical analyses were performed with STATISTICA for
Windows 8 (StatSoft, Inc). The statistical power of the sample
was estimated using the Sample Size Calculation and power
analysis module in STATISTICA. We used α (two-tailed) = 0.05
and β = 0.20 to detect a standardized effects size of 10% between
the two groups (Altman, 1991).
Before statistical procedures were applied, the data were tested
for a normal distribution using Levene’s test. A Mann-Whitney
U-test was used to compare the demographic characteristics
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TABLE 1 | Participant characteristics.
Val/Val (N = 13) Met/Met (N = 11) U p*
Age (years) 55 (48--61) 59 (51--65) 39.0 0.06
Years of education 3 (1--5) 3 (1--5) 62.0 0.58
Menarche (years) 13 (11--16) 13 (11--14) 69.0 0.88
Menopause (years) 43 (31--51) 47 (35--57) 46.5 0.15
Partus 2 (0--5) 4 (0--17) 53.5 0.30
Height (cm) 1.58 (1.53--1.64) 1.51 (1.12--1.77) 39.5 0.06
TAS (mmHg) 107 (90--140) 115 (90--140) 43.5 0.10
TAD (mmHg) 79 (60--90) 74 (50--90) 49.0 0.19
BMI (Kg/m2) 26.20 (20.58--33.28) 29.13 (20.78--38.44) 46.0 0.14
Values are shown as the median and range. *Mann-Whitney U Test. BMI = Body
Mass Index. TAS = Systolic arterial tension. TAD = Diastolic arterial tension.
between the Val/Val and Met/Met COMT genotypes, due to the
non-normal distribution of these variables. To examine group
differences in resting state EEG absolute power, and differences
in the eyes-closed and eyes-open conditions, we conducted a
repeated measures analysis of variance. The factorial ANOVA
2 × 3 repeated measures designs included 2 between-subjects
factors (Genotype: Val/Val genotype and Met/Met genotype)
and 3 within-subjects factors (Region: frontal, parietal, midline;
Bands: delta, theta, alpha1, alpha2, beta1, beta2; Condition:
eyes open, eyes closed). Significant interactions were analyzed
using separate ANOVAs and follow-up contrasts were computed
to explain the nature of significant effects. Age was included
as a covariate in all analyzes. We computed η2 values in
each ANOVA as a measure of effect size. Statistical analyses
included a general linear model. Bonferroni corrected post
hoc comparisons were computed to assess which genotypes
differed from each other with the significance level set at
p< 0.05.
Results
Characteristics of Participants
COMT genotype did not deviate from Hardy-Weinberg
equilibrium (X2 = 0.946). The characteristics of the participants
are shown in Table 1. The Val/Val and Met/Met individuals
did not differ significantly education level, age at menarche,
menopausal years, systolic arterial tension, diastolic arterial
tension, height, bodymass index, and pregnancies. Age tended to
be higher in the Met/Met group. However, age did not produce
significant differences when it was included as a covariate in all
analyzes.
Genotype Effects on Resting State EEG
We conducted an analysis of the absolute power derived from
EEG data in participants with Val/Val and Met/Met genotypes
for eyes-closed and eyes open rest conditions. Age did not show
a significant influence on the EEG analysis. The omnibus analysis
revealed main effects of Genotype (F(1) = 7.16, p = 0.008), Band
(F(5) = 541.24, p = 0.000001), Region (F(2) = 7.41, p = 0.0007) and
Condition (F(1) = 38.25, p = 0.000001), indicating that individuals
with Val/Val and Met/Met genotypes differed in the absolute
power of their EEG and that the differences varied by band,
region and condition.
The differences were also seen in a Genotype -by-Band
interaction (F(5) = 3.30, p = 0.005), Band-by-Region interaction
(F(10) = 4.43, p = 0.000004), Condition-by-Band interaction
(F(5) = 13.97, p = 0.000001), Condition-by-Region interaction
(F(2) = 6.93, p = 0.001) and Condition-by-Band-by-Region
interaction (F(10) = 2.84, p = 0.002). Given the main effects of
Genotype, Band, Region and Condition, and several interactions
we conducted ANOVAs and analysis of contrasts to elucidate the
group effects (Val/Val/ and Met/Met) across regions, bands and
conditions. Follow-up analysis showed that in individuals with
the Met/Met genotype, delta activity was increased in the eyes-
closed condition (F = 4.95, p = 0.03, η2 = 0.66, p = 0.11 corrected),
theta activity was increased in the eyes-closed (F = 7.02, p = 0.008,
η2 = 0.18, p = 0.03 corrected) and eyes-open conditions (F = 8.67,
p = 0.003, η2 = 0.24, p = 0.007 corrected), and the alpha1 band
(F = 9.67, p = 0.002, η2 = 0.25, p = 0.004 corrected), alpha2 band
(F = 19.14, p = 0.00002, η2 = 0.50, p = 0.00003 corrected), and
beta1 band (F = 5.40, p = 0.02, η2 = 0.54, p = 0.04 corrected) were
increased in the eyes-closed condition (Table 2).
Interactions
Figure 1 shows the main effects of the interactions of
genotypes for band, region and condition. The Genotype-
by-Band interaction was significant (F(5) = 3.30, p = 0.006)
(Figure 1A). Univariate results revealed that Met homozygote
individuals exhibited more delta (F = 4.66, p = 0.03), more theta
(F = 13.94, p = 0.0002) and more beta1 (F = 9.41, p = 0.002)
than individuals with the Val/Val genotype whereas the
alpha1, alpha2 and beta2 bands were not significantly different
between genotypes. The Genotype-by-Region interaction was
not significant (F(2) = 0.14, p = 0.87) (Figure 1B), indicating that
EEG power in the frontal, parietal and midline regions was not
affected by interactions between genotypes. The Genotype-by-
Condition interaction was not significant (F(1) = 0.09, p = 0.77)
(Figure 1C), indicating that EEG power in the eyes open and
eyes closed conditions was not affected by interactions between
genotypes.
Discussion
The results of this study demonstrate the effects of the COMT
Val158Met polymorphism on resting-state EEG power during the
eyes-closed and eyes-open states in healthy women. The main
finding was a significant interaction between genotypes and EEG
spectral bands.
The analysis of this interaction revealed that Met homozygote
women exhibited more delta, more theta and more beta1
activity than women with the Val/Val genotype, indicating a
significant effect of genotypes. Our follow-up analysis showed
that women carriers of the Met/Met genotype, who had more
DA available at the synapse, exhibited augmented absolute
power in the slow components of the spectrum: delta increased
in the eyes-closed condition, theta increased in both eyes-
closed and eyes-open conditions, and alpha1 increased in
the eyes open conditions. The absolute power of the fast
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TABLE 2 | Results of factorial ANOVA of absolute power between Val/Val and Met/Met genotypes with eyes closed and open.
COMT Val158Met genotype
Val/Val Met/Met
Condition Band mean (SD) mean (SD) F p Effect size, η2 Bonferroni correction
Eyes-closed Delta 14.62 (0.76) 17.12 (0.83) 4.95 0.03 0.66 0.11
Theta 4.33 (0.18) 5.04 (0.20) 7.02 0.008 0.18 0.03
Alpha 1 7.01 (0.53) 6.92 (0.58) 0.01 0.91 0.0007 3.63
Alpha 2 4.43 (0.38) 4.83 (0.41) 0.52 0.47 0.02 1.88
Beta 1 1.42 (0.06) 1.59 (0.07) 3.38 0.07 0.28 0.27
Beta 2 0.40 (0.04) 0.46 (0.04) 0.87 0.35 0.30 1.40
Eyes-open Delta 14.00 (1.14) 16.18 (1.24) 1.66 0.20 0.74 0.40
Theta 3.50 (0.17) 4.24 (0.18) 8.67 0.003 0.24 0.007
Alpha 1 2.59 (0.13) 3.18 (0.14) 9.67 0.002 0.25 0.004
Alpha 2 1.96 (0.11) 2.67 (0.12) 19.14 0.00002 0.50 0.00003
Beta 1 1.15 (0.08) 1.42 (0.09) 5.40 0.02 0.54 0.04
Beta 2 0.45 (0.06) 0.48 (0.07) 0.12 0.73 0.007 1.46
frequencies alpha2 and beta1were also increased in the eyes-
open conditions than women carriers of the Met/Met genotype.
Interestingly, we did not detect a Genotype by Region interaction,
indicating that resting-state EEG power in the frontal, parietal
and midline regions was not affected by interactions between
genotypes.
One explanation for the lack of COMT effects on EEG
regional power could be that the study lacked sensibility or
statistical power to detect an effect. The number of participants
included in our study was 24, which exceeded the number
required for a sample size with statistical power (n = 3)
according to our analysis. Indeed, in the contrast analysis,
a significant effect was found for beta1 activity, which was
elevated in the parietal and midline regions in individuals with
the Met/Met genotype. Furthermore, the beta1 band showed
a medium effect size in the sample, which describes the ratio
of variance explained in the dependent variable. However,
most of the comparisons between EEG regional power and
genotypes did not survive correction for multiple comparisons,
even after restriction of the analyses to certain regions and
conditions. Our results are partially consistent with a study
that investigated the effect of the COMT genotypes on BOLD
activation during a working memory task conducted with male
and female healthy subjects (Stokes et al., 2011). These authors
did not find that COMT genotype effected the prefrontal cortical
modulation of activity. Others studies that analyzed connectivity
between the hemispheres found low functional connectivity
in healthy young women with the Met/Met genotype (Lee
et al., 2011) and decreased prefrontal connectivity in the
frontal regions in individuals with Val/Val genotype (Liu et al.,
2010).
It is important to note that the women analyzed in the present
study were healthy volunteers without any apparent history
of hyperactivity disorder, anxiety, depression or psychiatric
disorders, which might influence EEG activity. COMT genotype
has been shown to affect resting state EEG regional power in
psychiatric patients. One study found that Met/Met patients
with schizophrenia exhibited lower alpha activity at frontal
and temporal sites than Val/Val patients (Venables et al.,
2009). Another study found that schizophrenic subjects with
the Met/Met genotype showed smaller P300 amplitudes than
subjects with the Val/Val genotype in the frontal region
during an auditory oddball paradigm (Gallinat et al., 2003).
Low-voltage alpha in resting EEG was associated with higher
anxiety scores in women with Met/Met genotype (Enoch
et al., 2003). In a heterogeneous sample including both
genders, increased resting posterior-versus- frontal delta/theta
EEG activity was associated with increased extraversion scores
in Val allele carriers (Lee et al., 2011). These reports
suggest that significant changes in EEG activity related to
COMT genotype are observed in individuals with mental
disorders.
The resting EEG is a dynamic index of cortical activation
and is therefore an intermediate phenotype for many behaviors
in which arousal is implicated. Although COMT may not
have a direct effect on resting-state EEG regional power,
we found evidence that COMT genotype effects resting-state
EEG spectral power. Our findings of higher absolute power
in the delta, theta and alpha1 bands in individuals with the
Met/Met genotype suggest a state of lower activation, whereas
the increase of alpha2 and beta1 absolute power suggests a
state of higher activation compared to women carriers of the
Val/Val genotype. Although it is not possible in the present
paradigm to draw conclusions about the consequences of
resting-state EEG power on the behavioral, emotional and
cognitive changes reported in the COMT genotypes, some
interesting correlations may be considered and deserve further
investigation. It has been reported that high absolute power of
slow bands is related to cortical inhibitory processes (Steriade
et al., 1990). Elevated theta and alpha1 power has been found
in Met allele carriers with schizophrenia (Venables et al.,
2009) and in individuals with attention-deficit/hyperactivity
disorder (Barry et al., 2003) compared with healthy subjects.
Brain activation studies have reported that the Met allele is
associated with attenuated brain activation in the posterior
cingulate gyrus and precuneus during the performance of
an emotional task (Swart et al., 2011). High power of fast
activity has been associated with arousal (Steriade, 1993), anxiety
(Lee and Prescott, 2014), emotional reactivity (Tumyalis and
Aftanas, 2014) and depression in females (Jaworska et al., 2012),
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FIGURE 1 | It shows the main effects of the interactions of genotypes
for band, region and condition. Panel (A) shows the Genotype-by-Band
interaction (p = 0.006) of delta, theta, alpha1, alpha2, beta1 and beta2
absolute power, log transformed (derivations pooled). Panel (B) shows the
Genotype-by-Region interaction (p = 0.87) of frontal, parietal and midline
regions (regions pooled). Panel (C) shows the Genotype-by-Condition
interaction (p = 0.77) of eyes open and eyes closed (conditions pooled).
Asterisks indicate the significance between Val/Val and Met/Met genotypes
(*p < 0.05).
suggesting increased emotive arousal. Although we did not
measure the affective state of the participants, we observed
alpha2 and beta1 absolute power increased in the individuals
with the Met/Met genotype compared to women carriers of the
Val/Val genotype, which may reflect arousal. Healthy individuals
with the Met/Met genotype experienced larger subjective stress
responses (Hernaus et al., 2013) and higher scores in the
disorganization domain of the SPQ-B personality inventory
(Sheldrick et al., 2008). Future studies on the COMT gene
and EEG activity should consider the emotional status of the
participants.
The EEG profile of the COMT Val158Met polymorphism
described in our study may be related to the resting state
functional brain through dopamanergic effects. Our findings are
supported by the tonic and phasic DA theory and the influence of
COMT on dopamanergic activity (Bilder et al., 2004). This theory
assumes that COMT serves to modulate the balance of tonic and
phasic DA function subcortically, and overall DA transmission
cortically, the effect of the Met allele would be to increase tonic
DA levels and decrease phasic DA release in subcortical regions,
and increased DA concentrations in cortex, thereby enhancing
the functions associated with tonic DA system activity and
D1 stimulation cortically. In contrast, the Val allele would be
expected to have complementary effects, increasing phasic DA
transmission and D2 stimulation subcortically, while decreasing
tonic DA neurotransmission subcortically and decreasing overall
DA concentrations in the prefrontal cortex, thereby reducing
cortical D1 neurotransmission.
These effects of the COMT gene may have an impact on
the resting-state EEG spectral power of postmenopausal healthy
females.
In conclusion, we have shown that the COMT Val158Met
polymorphism does not directly impact resting-state EEG
regional power modulation. Instead, we found that individuals
with the Met/Met genotype showed a state of lower activation
in resting-state EEG spectral power, denoted by delta and
theta activities, and a state of higher activation denoted
by beta1 activity, which may have functional effects. These
results imply that COMT genotype status impacts resting-
state EEG spectral power. These EEG profiles may serve as
an endophenotypes, reflecting cortical influence of the COMT
genotype on tonic and phasic dopamanergic function in healthy
females.
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